Literature DB >> 10920168

American Academy of Pediatrics. Committee on Substance Abuse and Committee on Children With Disabilities. Fetal alcohol syndrome and alcohol-related neurodevelopmental disorders.

.   

Abstract

Prenatal exposure to alcohol is one of the leading preventable causes of birth defects, mental retardation, and neurodevelopmental disorders. In 1973, a cluster of birth defects resulting from prenatal alcohol exposure was recognized as a clinical entity called fetal alcohol syndrome. More recently, alcohol exposure in utero has been linked to a variety of other neurodevelopmental problems, and the terms alcohol-related neurodevelopmental disorder and alcohol-related birth defects have been proposed to identify infants so affected. This statement is an update of a previous statement by the American Academy of Pediatrics and reflects the current thinking about alcohol exposure in utero and the revised nosology.

Entities:  

Mesh:

Year:  2000        PMID: 10920168

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  51 in total

1.  Women's Knowledge, Views, and Experiences Regarding Alcohol Use and Pregnancy: Opportunities to Improve Health Messages.

Authors:  Elvira Elek; Shelly L Harris; Claudia M Squire; Marjorie Margolis; Mary Kate Weber; Elizabeth Parra Dang; Betsy Mitchell
Journal:  Am J Health Educ       Date:  2013-06-28

2.  Effects of prenatal alcohol exposure and attention-deficit/hyperactivity disorder on adaptive functioning.

Authors:  Ashley L Ware; Leila Glass; Nicole Crocker; Benjamin N Deweese; Claire D Coles; Julie A Kable; Philip A May; Wendy O Kalberg; Elizabeth R Sowell; Kenneth L Jones; Edward P Riley; Sarah N Mattson
Journal:  Alcohol Clin Exp Res       Date:  2014-03-21       Impact factor: 3.455

3.  A Dual-Focus Motivational Intervention to Reduce the Risk of Alcohol-Exposed Pregnancy.

Authors:  Mary M Velasquez; Karen S Ingersoll; Mark B Sobell; R Louise Floyd; Linda Carter Sobell; Kirk von Sternberg
Journal:  Cogn Behav Pract       Date:  2010-05-01

4.  First trimester alcohol exposure alters placental perfusion and fetal oxygen availability affecting fetal growth and development in a non-human primate model.

Authors:  Jamie O Lo; Matthias C Schabel; Victoria H J Roberts; Xiaojie Wang; Katherine S Lewandowski; Kathleen A Grant; Antonio E Frias; Christopher D Kroenke
Journal:  Am J Obstet Gynecol       Date:  2017-01-30       Impact factor: 8.661

5.  Transgenerational effects of binge drinking in a primate model: implications for human health.

Authors:  Catherine A VandeVoort; Kristin N Grimsrud; Uros Midic; Namdori Mtango; Keith E Latham
Journal:  Fertil Steril       Date:  2014-12-06       Impact factor: 7.329

6.  Neuropsychological deficits associated with heavy prenatal alcohol exposure are not exacerbated by ADHD.

Authors:  Leila Glass; Ashley L Ware; Nicole Crocker; Benjamin N Deweese; Claire D Coles; Julie A Kable; Philip A May; Wendy O Kalberg; Elizabeth R Sowell; Kenneth Lyons Jones; Edward P Riley; Sarah N Mattson
Journal:  Neuropsychology       Date:  2013-09-16       Impact factor: 3.295

7.  Ethical, legal and policy issues in management of fetal alcohol spectrum disorder.

Authors:  Chris Hackler
Journal:  J Ark Med Soc       Date:  2011-11

8.  Alcohol and drug use before and during pregnancy: an examination of use patterns and predictors of cessation.

Authors:  Patricia A Harrison; Abbey C Sidebottom
Journal:  Matern Child Health J       Date:  2008-05-03

Review 9.  Foetal Alcohol Spectrum Disorders and alterations in brain and behaviour.

Authors:  Consuelo Guerri; Alissa Bazinet; Edward P Riley
Journal:  Alcohol Alcohol       Date:  2009-01-15       Impact factor: 2.826

10.  The feasibility and cost of neonatal screening for prenatal alcohol exposure by measuring phosphatidylethanol in dried blood spots.

Authors:  Ludmila N Bakhireva; Renate D Savich; Dennis W Raisch; Sandra Cano; Robert D Annett; Lawrence Leeman; Mahek Garg; Chelsea Goff; Daniel D Savage
Journal:  Alcohol Clin Exp Res       Date:  2013-02-19       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.